Skip to main content
Equibles

GSA CAPITAL PARTNERS LLP

Position in CRDF — Cardiff Oncology, Inc.

CIK 1362033 LONDON, X0
Back to CRDF Full portfolio

Position in CRDF

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$225,256
+$25,984 QoQ
Shares Held
173,274
+40.9% QoQ
Ownership
0.223%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 104 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRDF Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names. CRDF ranks #123 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IOVA
Iovance Biotherapeutics, Inc.
 655,318 $2,726,122
2 IMVT
Immunovant, Inc.
 65,267 $2,514,737
3 GOSS
Gossamer Bio, Inc.
 187,337 $2,472,846
4 AXSM
Axsome Therapeutics, Inc.
 9,419 $2,305,488
5 CABA
Cabaletta Bio, Inc.
 668,563 $2,079,230
6 MLTX
MoonLake Immunotherapeutics
 106,695 $2,077,351
7 ATYR
aTYR PHARMA INC
 3,454,863 $2,062,553
8 CORT
Corcept Therapeutics Inc
 23,257 $2,022,196

All Filings in CRDF

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $225,256 173,274
2026-03-31 $199,272 123,008
2025-12-31 $592,572 210,880
2025-06-30 $408,652 129,731
2025-03-31 $1,113,308 354,557
2024-12-31 $1,649,503 380,070
2024-09-30 $498,355 186,650
2024-06-30 $77,782 35,037
2023-09-30 $36,105 25,975
2023-06-30 $436,115 296,677
2023-03-31 $463,120 280,679
2022-12-31 $493,060 352,186
2022-09-30 $181,525 117,874
2022-06-30 $258,049 117,295
2022-03-31 $158,097 63,749
2021-12-31 $93,227 15,512
2021-06-30 $161,023 24,214